1. Hem Investigators 2017 | Interview with Jonathan W Friedberg, MD, MMSc

2.  Hem Investigators 2017 | Interview with S Vincent Rajkumar, MD

3. MPNUpdate117 | Interview with Professor Claire N Harrison, MD

4. MPNUpdate117 | Interview with Srdan Verstovsek, MD, PhD

5. Lymphoma CLL Update 1 2017 | Interview with Stephen Maxted Ansell, MD, PhD

6. Lymphoma CLL Update 1 2017 | Interview with Ann S LaCasce, MD, MMSc

7. MDSU1 2017 | Interview with Mikkael A Sekeres, MD, MS

8. MDSU1 2017 | Interview with Steven D Gore, MD

9. MMTT1 2017 | Current Clinical Algorithms and Recent Therapeutic Advances in the Management of Multiple Myeloma and Related Blood Disorders

10. Beyond the Guidelines 16 | Interview with Morie A Gertz, MD, MACP

11. Beyond the Guidelines 16 | Interview with Julie M Vose, MD, MBA

12. HOU3 2016 | Interview with Laurie H Sehn, MD, MPH

13. HOU3 2016 | Interview with Sagar Lonial, MD

14. HOU3 2016 | Interview with Raoul Tibes, MD, PhD

15. HOU3 2016 | Interview with Loretta J Nastoupil, MD

16. MTP AML 2017 | Meet The Professors: A Case-Based Discussion on the Management of Acute Myeloid Leukemia

1. LCU1 2017 | Interview with D Ross Camidge, MD, PhD

2. LCU1 2017 | Interview with Heather Wakelee, MD

3. Morbidity and Mortality 2017 Lung | A Roundtable Discussion Featuring Heather Wakelee, MD, Maria Picton, MD and Estelamari Rodriguez, MD, MPH

4. LCU3 2016 | Interview with Tony SK Mok, MD

5. LCU3 2016 | Interview with George R Blumenschein Jr, MD

6. LCU2 2016 | Interview with Roy S Herbst, MD, PhD

7. LCU2 2016 | Interview with Alice Shaw, MD, PhD

8. LCU1 2016 | Interview with Bruce E Johnson, MD

9. LCU1 2016 | Interview with Thomas E Stinchcombe, MD

1. Colorectal Cancer Therapy Gets a Tune-up: ESMO 2017

2 New Data Provide Even More Support for Exercise During Cancer

3. PIVOT: Latest Data on Surveillance Versus Surgery for Prostate Cancer

4. Ethical Malpractice in American Clinical Oncology

5. Pembrolizumab, Larotrectinib Point to Future of Precision Medicine

6. New Data Address Critical Surgical Questions in Ovarian Cancer

7. Potential ASCO Practice-Changers in HER2+ Breast Cancer

8. Cultivating Resiliency and Combating Burnout in Oncology

9. A New Standard for Low-Grade Serous Cancer of the Ovary?

 10. New ASCO Guideline for NSCLC: ‘Precision Medicine at Its Best’

11. New CDK4/6i Data Move Metastatic Breast Cancer Field Forward

12. Will pCR and Pembro Redefine Breast Cancer Treatment?

13. Good IDEA: Drop Adjuvant Chemo From 6 to 3 Months in CRC

14. Top Melanoma Studies to Be Presented at ASCO